TMJ Disorders Market Research Report - Forecast till 2027

TMJ Disorders Market: Information By Type (Myofascial Pain, Internal Derangement, Arthritis), Treatment (Medication, Therapies, Surgical Treatment), End User (Hospitals & Clinics, Ambulatory Surgery Center, Research and Academic Institutes) and Region (Americas, Europe, Asia-Pacific, the Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/2758-CR | March 2021 | Region: Global | 111 Pages         

TMJ Disorders Market Speak to Analyst Request a Free Sample

TMJ Disorders Market

The TMJ Disorders Market was valued at USD 650.07 Million in 2019 and is expected to register a CAGR of 4.18 % during the forecast period of 2020 to 2027.

By Type Myofascial Pain Internal Derangement Arthritis
By Treatment Medication Therapies Surgical Treatment
By End User Hospitals & Clinics Ambulatory Surgery Center Research Academic Institutes
By Region Americas Europe Asia-Pacific The Middle East & Africa
Key Players
Companies Profiled   Sun Pharmaceutical Industries Limited   Abbott Laboratories   Mylan NV   Teva Pharmaceutical Industries Ltd   Bristol-Myers Squibb Company   Bayer AG   Allergan   Zydus Cadila   Jubilant Life Sciences Limited   Novartis International AG.
Market Driving Forces   Rising introduction and rapid adoption of advanced treatments   Easy availability of medicines   Increasing prevalence of TMJ disorder   Rise in healthcare spending worldwide
Request a Free Sample

TMJ Disorders Market Overview

The TMJ Disorders Market was valued USD 650.07 Million in 2019. Further, the worldwide market is anticipated to account for a CAGR of 4.18 % between the forecast period of 2020 to 2027. The TMJ disorders are widely called a temporomandibular muscle and joint disorders. This disorder is a medical condition that creates pain and dysfunction in the muscles and jaw joint that controls jaw movement. As per the research results, TMJ disorders are found very common among the women population compared to the mean population. Additionally, women who use oral contraceptives or supplemental estrogen are more likely to require treatment for the following condition. Thus, the increasing prevalence of these disorders across the world is projected to fuel the global market growth. 

According to the 2018 report of the National Institute of Dental and Craniofacial Research, the prevalence of TMJ disorders was high among youngsters, and it was between 5% to 12%. The TMJ incidence usually peaks in between the age group of 20 to 40 years. Moreover, this disorder is considered to be the second-most common musculoskeletal condition that causes disability and Pain. The demand for TMJ Disorders Market is growing due to the rising research studies relating to the study of the prevalence of TMJ disorders. In 2016, the North Saudi Arabia university students conducted a prevalence study that has helped to identify that the student has a high prevalence rate. 

The TMJ Disorders Market Forecast report highlights that the intended audiences of the present market are contributing to the global market growth. These intended audiences include research and development (R&D) companies, medical research laboratories, TMJ disorders diagnostic and treatment companies, potential investors, market research and consulting service providers, and TMJ disorders treatment service, providers. 

COVID-19 Analysis

The Covid-19 pandemic has affected the TMJ Disorders Market in the first half of 2020. At this time, the disruption in the manufacturing chain and supply chain has been evident due to the lockdown and shutdown of many countries. People were unable to diagnose, and even many appointments have been postponed at this time. 

However, the key players have taken initiatives by doping new strategies and measures to bring back its popularity. Likely, it is predicted that the global market will thrive in the further coming years. 

Market Dynamics

  • Key Market Drivers

The increasingly rapid adoption of advanced treatments, rising prevalence of TMJ disorders, easy availability of medicines, and increasing healthcare spending among the demography are some of the important growth driving factors to the global Market during the assessment period. 

Moreover, the increasing technological advancement is driving the TMJ disorders market growth during the forecast period. 

  • Market Challenges

The TMJ disorders market might experience challenges due to the high cost associated with the treatment of TMJ disorders. 

Moreover, the diagnosis and treatment of TMJ disorders require highly skilled professionals and specialists, which can be one of the major challenges for the market in the review period. 

  • Market Opportunities

The global market vendors and manufacturers have significant opportunities in the TMJ disorders market due to the rising advanced diagnostic and therapeutic options across the world. 

Additionally, the academic institutes and medical research laboratories are leading to new developments that can bring new opportunities for the TMJ disorders market in the forecast timeframe. 

  • Market Restraints

The huge cost of treatment for the TMJ Disorders might hinder the growth of the TMJ disorders market during the research period. 

Moreover, the stringent regulation of government on pharmaceutical companies might be one of the reasons that can affect the global market growth in the upcoming years. 

Cumulative Evaluation Of The Market

In the past few years, the global market for TMJ Disorders has witnessed significant growth. Furthermore, the key players are focusing on expanding their product portfolio and providing advanced medical devices for the treatment of myofascial pain syndrome, which is projected to enhance the global TMJ Disorders Market Size in the upcoming years. 

Market Segmentation

As per the TMJ Disorders Market Trends report, the current market has been segmented on the basis of treatment, type and end-users.

  • By Treatment:

In terms of the treatment segment, the worldwide TMJ Disorders Market has been segregated into therapies, medication, surgical, and others.

Further, the medication segment is sub-divided into anti-inflammatories, pain relievers, muscle relaxants, tricyclic antidepressants, and others. 

  • By type:

On the basis of type segment, the global Market has been classified into Internal Derangement (ID), myofascial pain, and Osteoarthritis. 

Among these segments, the myofascial Pain segment is projected to generate the largest TMJ Disorders Market Share during the review timeframe. 

  • By end-users:

Depending on the end-user segment, the TMJ Disorders Market has been categorized into academic institutes, ambulatory surgery centers, hospitals and clinics, and others.

In the past few years, the global Market has experienced promising growth because of the easy availability of medicines and rapid adoption of advanced treatments. Here, the ambulatory surgery centers segment is projected to witness high growth in the global market due to its cost-effectiveness. This trend is estimated to continue in the further coming years. 

Regional Analysis

Geographically, the TMJ Disorders Market has been classified based on different locations such as the Middle East & Africa, Asia-Pacific, Europe, North America, Latin America, and the rest of the world. 

In 2019, the Latin American and North American regional market was projected to account for the largest share of 49.20% due to the increasing introduction and rapid adoption of advanced treatments. Further, this region is estimated to generate higher TMJ Disorders Market Value in the forecast period. Among all the regions, the European market is projected to hold the second-largest position for the year 2019 due to the presence of a well-developed medical industry and the huge spending on healthcare in the region. This region is expanding because of the rising cases of TMJ disorder and accessibility to advanced therapeutic and diagnostic options in the region. Moreover, the key players of these regions are working effectively to enhance the regional market growth in the forecast period. 

Further, the AsiaPacific market for TMJ Disorders is anticipated to generate the highest growth rate during the review period of 2020 to 2027. This region is highly contributed with the increased government initiative, high incidence of TMJ disorder, and the presence of the biggest pharmaceutical companies in the region. In the past few years, the Middle East & Africa regional market has shown steady growth due to the rising funding by government bodies and private players and the high prevalence of TMJ disorder in the region. 

Competitive Intensity Within The Industry 

As per the TMJ Disorders Market Analysis, significant competition among the prominent market players has been witnessed in the global market. These competitive market vendors are:

  • Sun Pharmaceutical Industries Limited,

  • Abbott Laboratories,¬†

  • Mylan NV,

  • Teva Pharmaceutical Industries Ltd,¬†

  • Bristol-Myers Squibb Company,

  • Bayer AG,¬†

  • Allergan,

  • Zydus Cadila,¬†

  • Jubilant Life Sciences Limited,

  • Novartis International AG.

According to the TMJ Disorders Market Outlook report, these prominent market players are investing highly in research and development initiatives relating to TMJ Disorders. Moreover, the market vendors are focusing on new innovations and advancements of technology to enhance the global market for TMJ Disorders. 

Recent Market Developments

  • Recently, MJ Health has introduced its TMJ NextGeneration Device offering that has approval from U.–Ö. F–ĺ–ĺd–įnd Drug –źdm—Ėn—Ė—ētr–įt—Ė–ĺn(FDA). This device has been proposed to alleviate temporomandibular joint disorder (TMJD) pain.

  • Recently, the prominent player –źLL–ēRG–źN has declared that it can market –ąUV√ČD–ēR–ú V–ěLLUR–ē –•–° across the world as it has received the approval from US FDA. It has the capacity to —Ā–ĺrr–Ķ—Ātthe moderatet–ĺ—ē–Ķv–Ķr–Ķf–į—Ā—Ė–įlfolds and wr—Ėnkl–Ķ—ēamong the age of 21 ad above.¬†

Report Overview

The TMJ Disorders Market report is a detailed analysis of both qualitative and quantitative research. In this report, the major focus has been given to the growing performance of the global market. This report has covered the recent development, market segments, market dynamics, market overview, regional classifications, and competitive analysis. 

Moreover, this report has also highlighted the covid-19 analysis where it has mentioned the slow down of the global market that has impacted the global market growth in the forecast period. 

Key Industrial Segments

By Treatment:

  • therapies,¬†

  • medication,¬†

  • surgical,¬†

  • others

By type:

  • Internal Derangement (ID),¬†

  • myofascial Pain,¬†

  • Osteoarthritis

By end-users:

  • academic institutes,¬†

  • ambulatory surgery centers,¬†

  • hospitals and clinics,¬†

  • others

Report Scope:

Report Attribute/Metric Details
  Market Size   USD 650.07 Million
  CAGR   2020-2027: 4.18%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Type, Treatment and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Allergan, Bayer AG, Zydus Cadila, Mylan NV, Novartis International AG, and Jubilant Life Sciences Limited
  Key Market Opportunities

  • advanced diagnostic and therapeutic options
  • Medical research laboratories and academic institutes are leading to new developments
  •   Key Market Drivers

  • Rising introduction and rapid adoption of advanced treatments and easy availability of medicines
  • Increasing prevalence of TMJ disorders
  • Rise in healthcare spending worldwide

  • Speak to Analyst Ask for Customization